353 related articles for article (PubMed ID: 9164365)
1. Continuous avoidance measures with or without acaricide in dust mite-allergic asthmatic children.
Bahir A; Goldberg A; Mekori YA; Confino-Cohen R; Morag H; Rosen Y; Monakir D; Rigler S; Cohen AH; Horev Z; Noviski N; Mandelberg A
Ann Allergy Asthma Immunol; 1997 May; 78(5):506-12. PubMed ID: 9164365
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of the acaricide: acardust for the prevention of asthma and rhinitis due to dust mite allergy, in children.
Geller-Bernstein C; Pibourdin JM; Dornelas A; Fondarai J
Allerg Immunol (Paris); 1995 May; 27(5):147-54. PubMed ID: 7662102
[TBL] [Abstract][Full Text] [Related]
3. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
[TBL] [Abstract][Full Text] [Related]
4. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
[TBL] [Abstract][Full Text] [Related]
5. The respiratory effects of reduction of mite allergen in the bedrooms of asthmatic children--a double-blind controlled trial.
Carswell F; Birmingham K; Oliver J; Crewes A; Weeks J
Clin Exp Allergy; 1996 Apr; 26(4):386-96. PubMed ID: 8732235
[TBL] [Abstract][Full Text] [Related]
6. Effect of application of benzyl benzoate on house dust mite allergen levels.
Chang JH; Becker A; Ferguson A; Manfreda J; Simons E; Chan H; Noertjojo K; Chan-Yeung M
Ann Allergy Asthma Immunol; 1996 Sep; 77(3):187-90. PubMed ID: 8814042
[TBL] [Abstract][Full Text] [Related]
7. Dust mite allergen avoidance in the treatment of hospitalized children with asthma.
Hayden ML; Perzanowski M; Matheson L; Scott P; Call RS; Platts-Mills TA
Ann Allergy Asthma Immunol; 1997 Nov; 79(5):437-42. PubMed ID: 9396978
[TBL] [Abstract][Full Text] [Related]
8. Allergen avoidance in house dust mite sensitive adult asthma.
Walshaw MJ; Evans CC
Q J Med; 1986 Feb; 58(226):199-215. PubMed ID: 3520626
[TBL] [Abstract][Full Text] [Related]
9. Clinical effectiveness of a mite allergen-impermeable bed-covering system in asthmatic mite-sensitive patients.
van den Bemt L; van Knapen L; de Vries MP; Jansen M; Cloosterman S; van Schayck CP
J Allergy Clin Immunol; 2004 Oct; 114(4):858-62. PubMed ID: 15480327
[TBL] [Abstract][Full Text] [Related]
10. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
11. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
Halken S
Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
[TBL] [Abstract][Full Text] [Related]
12. Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthma.
Woodcock A; Forster L; Matthews E; Martin J; Letley L; Vickers M; Britton J; Strachan D; Howarth P; Altmann D; Frost C; Custovic A;
N Engl J Med; 2003 Jul; 349(3):225-36. PubMed ID: 12867606
[TBL] [Abstract][Full Text] [Related]
13. House dust mite allergen avoidance and self-management in allergic patients with asthma: randomised controlled trial.
de Vries MP; van den Bemt L; Aretz K; Thoonen BP; Muris JW; Kester AD; Cloosterman S; van Schayck CP
Br J Gen Pract; 2007 Mar; 57(536):184-90. PubMed ID: 17359604
[TBL] [Abstract][Full Text] [Related]
14. Dust-free bedrooms in the treatment of asthmatic children with house dust or house dust mite allergy: a controlled trial.
Murray AB; Ferguson AC
Pediatrics; 1983 Mar; 71(3):418-22. PubMed ID: 6338475
[TBL] [Abstract][Full Text] [Related]
15. House dust mite and cockroach exposure are strong risk factors for positive allergy skin test responses in the Childhood Asthma Management Program.
Huss K; Adkinson NF; Eggleston PA; Dawson C; Van Natta ML; Hamilton RG
J Allergy Clin Immunol; 2001 Jan; 107(1):48-54. PubMed ID: 11149990
[TBL] [Abstract][Full Text] [Related]
16. Effect of house dust mite immunotherapy on transforming growth factor beta1-producing T cells in asthmatic children.
Ajduk J; Marinic I; Aberle N; Rabatic S; Gagro A
Ann Allergy Asthma Immunol; 2008 Apr; 100(4):314-22. PubMed ID: 18450115
[TBL] [Abstract][Full Text] [Related]
17. Effects of house dust mite avoidance measures on Der p 1 concentrations and clinical condition of mild adult house dust mite-allergic asthmatic patients, using no inhaled steroids.
Cloosterman SG; Schermer TR; Bijl-Hofland ID; Van Der Heide S; Brunekreef B; Van Den Elshout FJ; Van Herwaarden CL; Van Schayck CP
Clin Exp Allergy; 1999 Oct; 29(10):1336-46. PubMed ID: 10520054
[TBL] [Abstract][Full Text] [Related]
18. House dust control and asthma: a placebo-control trial of cleaning air filtration.
Bowler SD; Mitchell CA; Miles J
Ann Allergy; 1985 Sep; 55(3):498-500. PubMed ID: 4037436
[TBL] [Abstract][Full Text] [Related]
19. Effect of specific immunotherapy added to pharmacologic treatment and allergen avoidance in asthmatic patients allergic to house dust mite.
Maestrelli P; Zanolla L; Pozzan M; Fabbri LM;
J Allergy Clin Immunol; 2004 Apr; 113(4):643-9. PubMed ID: 15100667
[TBL] [Abstract][Full Text] [Related]
20. The Melbourne House Dust Mite Study: long-term efficacy of house dust mite reduction strategies.
Sporik R; Hill DJ; Thompson PJ; Stewart GA; Carlin JB; Nolan TM; Kemp AS; Hosking CS
J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):451-6. PubMed ID: 9564796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
